BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6509818)

  • 21. Ocular assessment of patients treated with tamoxifen.
    Beck M; Mills PV
    Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonproliferative epithelial alteration and expression of estrogen receptor and Ki67 in the contralateral breast of women treated with tamoxifen for breast cancer.
    de Souza Sales JF; Cabello C; Alvarenga M; Torresan RZ; Duarte GM
    Breast; 2007 Apr; 16(2):197-203. PubMed ID: 17178225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
    Chrapusta SJ; Giermek J; Pieńkowski T
    Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
    Brufman G
    Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
    Cataliotti L; Buzdar AU; Noguchi S; Bines J; Takatsuka Y; Petrakova K; Dube P; de Oliveira CT
    Cancer; 2006 May; 106(10):2095-103. PubMed ID: 16598749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen therapy for advanced ovarian cancer.
    Schwartz PE; Keating G; MacLusky N; Naftolin F; Eisenfeld A
    Obstet Gynecol; 1982 May; 59(5):583-8. PubMed ID: 7070729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of advanced breast cancer with tamoxifen (author's transl)].
    Alonso Muñóz A; Pérez Manga G; Moreno Esteban B; Muñóz Gómez S; Madrigal Alonso PL; Pérez Modrego S
    Med Clin (Barc); 1980 Jul; 75(3):93-7. PubMed ID: 7401744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.
    Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M
    Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of advanced breast cancer effectively treated with tamoxifen].
    Nakagawa K; Shibata C; Momono S; Sasaki Y; Furusawa A; Sato T
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1391-4. PubMed ID: 1503489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
    Edmonson JH; Krook JE; Hilton JF; Long HJ; Cullinan SA; Everson LK; Malkasian GD
    Cancer Treat Rep; 1986 Aug; 70(8):1019-20. PubMed ID: 3731147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant endocrine therapy of breast cancer].
    Jonat W; Maass H
    ZFA (Stuttgart); 1983 Apr; 59(10):571-4. PubMed ID: 6868762
    [No Abstract]   [Full Text] [Related]  

  • 36. Extended tamoxifen therapy for advanced breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1986 Dec; 69(12):635-40. PubMed ID: 3572276
    [No Abstract]   [Full Text] [Related]  

  • 37. Tamoxifen in the treatment of advanced breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1986 Feb; 69(2):96-102. PubMed ID: 3011939
    [No Abstract]   [Full Text] [Related]  

  • 38. Tamoxifen in the treatment of male breast carcinoma.
    Ribeiro GG
    Clin Radiol; 1983 Nov; 34(6):625-8. PubMed ID: 6673881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results with tamoxifen in advanced mammary carcinoma.
    Kolb R; Jakesz R; Reiner H
    Recent Results Cancer Res; 1980; 71():146-8. PubMed ID: 7367726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor determination predicts response to tamoxifen therapy.
    Allegra JC; Lippman ME
    Recent Results Cancer Res; 1980; 71():16-9. PubMed ID: 7367729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.